Cantor’s Louise Chen shares a bullish take on VRX following its first quarter print and plans for a name change to Bausch Health Companies.
MKM’s Ruben Roy continues to survey NVDA from the sidelines ahead of this week’s first quarter print.
GoPro (NASDAQ:GPRO) provided fresh evidence of its turnaround on Thursday by posting a first-quarter earnings beat and sales that fell much less than Wall …
Even with the slight lift in target expectations, Wells Fargo’s Peter Stabler still spotlights 3% in loss potential for P shares.
Both Baird’s Colin Sebastian as well as SunTrust’s Youssef Squali continue to back Alibaba’s long-term opportunity following the financial showcase.
Wedbush’s Michael Pachter spotlights upside potential ahead considering the robust ATVI lineup for the year.
While Wall Street was less impressed with SQ’s second quarter EBITDA guide, here’s why Oppenheimer’s Jed Kelly is sticking tight with the bulls:
Though Goldman Sachs’ Toshiya Hari is upbeat on chances for NVDA to dish out a first quarter beat, he suggests apprehension when it comes to the second quarter guide.
Tigress’ Ivan Feinseth anticipates the Street will send AMZN shares to even loftier valuation as long as its stellar growth steams ahead.
Though Teva served up a strong first quarter for 2018, BTIG’s Tim Chiang continues to make a bearish case on this challenged Israeli pharma giant.
